Keyphrases
Rhabdomyosarcoma
100%
Drug Target
100%
Nuclear Receptor 4A1
100%
Rhabdomyosarcoma Cells
46%
Knockdown
23%
Mammalian Target of Rapamycin (mTOR)
15%
RNA Interference
15%
Growth Factors
15%
Solid Tumors
7%
Adverse Effects
7%
Tumor
7%
Cell Proliferation
7%
Pathway Genes
7%
Induced Apoptosis
7%
Cell Growth
7%
Mutant p53
7%
Oncogenic Activity
7%
Associated Genes
7%
Tumor Growth
7%
Oxidative Stress
7%
Novel Mechanism
7%
Interference Test
7%
Cytotoxic Therapy
7%
Orphan nuclear Receptor
7%
Stress-induced
7%
Stress-responsive Genes
7%
Transactivation
7%
Pro-survival
7%
GC-rich
7%
Methane
7%
Hydroxyl
7%
Gene Pathway
7%
Polymerase
7%
Mechanistic Approach
7%
Carboxymethylation
7%
Annexin V Staining
7%
Isocitrate Dehydrogenase 1 (IDH1)
7%
Sestrin2
7%
Pro-oncogenic
7%
Indolyl
7%
Substituted Phenyl
7%
Thioredoxin Domain Containing 5
7%
Pro-survival Genes
7%
Pharmacology, Toxicology and Pharmaceutical Science
Rhabdomyosarcoma
100%
Cell Nucleus Receptor
100%
Protein P53
15%
Diseases
7%
Neoplasm
7%
Solid Malignant Neoplasm
7%
Tumor Growth
7%
Receptor
7%
Cytotoxic Chemotherapy
7%
Lipocortin 5
7%
Orphan Nuclear Receptor
7%
Thioredoxin
7%
Isocitrate Dehydrogenase 1
7%